Abnormal Patient Test Results Study

  • Research type

    Research Study

  • Full title

    Follow-up of Abnormal Patient Test Results in Primary Care

  • IRAS ID

    168736

  • Contact name

    Sarah Patricia Slight

  • Contact email

    sarah.slight@newcastle.ac.uk

  • Sponsor organisation

    Newcastle University

  • Duration of Study in the UK

    0 years, 36 months, 0 days

  • Research summary

    Pathology laboratories in the U.K. send approximately 50 million electronic results reports to GPs annually. Most tests are normal and do not require follow-up. However, the management of abnormal patient test results is a complex process. Failure to appropriately follow-up these results in a timely manner can have direct clinical consequences for patients, including missed diagnoses and delayed treatment. The aim of this study is to evaluate the follow-up of abnormal test results in U.K. primary care, and to explore staff experiences of where breakdowns might occur in the results management process.

    We will obtain data on four commonly performed patient tests (e.g., mammograms, pap smears, PSAs, and INRs) in nine participating GP practices (Primary Care Sites). These tests are used for the early detection of breast cancer, cervical cancer, prostate cancer, and for evaluation of blood coagulation, respectively. A combination of quantitative and qualitative techniques will be used. We will measure the frequency of failures at each step in the results management process. For those results that have appropriate follow-up documented, we will also collect data on the rate of timely follow-up of care. We would also like to interview staff across the nine GP practices to explore their experiences of where breakdowns might occur in the results management process, and how the follow-up of abnormal test results can be improved based on users’ experiences of current electronic systems.

  • REC name

    London - Stanmore Research Ethics Committee

  • REC reference

    16/LO/1551

  • Date of REC Opinion

    28 Sep 2016

  • REC opinion

    Further Information Favourable Opinion